Relative cell viability of IGROV1-CP cells with different treatments.

High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis

Hamelers, I.H.L.
Staffhorst, R.W.H.M.
Voortman, J.
de Kruijff, B.
Reedijk, J.
van Bergen en Henegouwen, P.M.P.
de Kroon, A.I.P.M.

January 2009

Purpose: Cisplatin nanocapsules, nanoprecipitates of cisplatin encapsulated in phospholipid bilayers...

Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants

Gil, Sílvia
Solano, Eduardo
Martínez-Trucharte, Francesc
Martínez-Esaín, Jordi
Pérez-Berná, Ana J.
Conesa, José Javier
Kamma-Lorger, Christina
Alsina, Mercè
Sabés Xamaní, Manuel

January 2020

The objective of this study was to regulate the cytotoxicity of cisplatin (cisPt) minimizing its adv...

Cytotoxicity assays of MCF-7 (Left) and HepG2 cells (Right) treated for 4 hours with plain nanoparticles (NP), free paclitaxel (PTX), PTX-loaded NPs (PTX-NP), PTX-loaded NPs conjugated to random DNA (PTX-R-NP), or PTX-loaded NPs conjugated to MUC1 aptamer (PTX-Apt-NP).

Chenchen Yu (345138)
Yan Hu (30839)
Jinhong Duan (331629)
Wei Yuan (64653)
Chen Wang (88408)
Haiyan Xu (148626)
Xian-Da Yang (331633)

February 2013

The cells were subsequently washed and incubated in culture media for a total of 48 hours, before...

Effect of cisplatin-loaded nanoparticles on athymic mice.

Lihua Cheng (191638)
Chengmeng Jin (191632)
Wen Lv (112411)
Qiuping Ding (343405)
Xu Han (141301)

February 2013

(A) Effect of free cisplatin (3 mg/kg) and cisplatin-loaded nanoparticles (NPs-cp, 3 mg/kg on the...

QBC939 cells are resistant to cisplatin.

Xianzhi Qu (3843163)
Jiyao Sheng (3577733)
Luyan Shen (3843166)
Jing Su (23377)
Yunjie Xu (793634)
Qi Xie (230608)
Yao Wu (598978)
Xuewen Zhang (1774840)
Liankun Sun (155927)

March 2017

QBC939 and HepG2 cells were treated with cisplatin for 12 or 24 h, and then cell viability, apopt...

P-gp in IGROV-1 and IGROVCDDP cells.

Britta Stordal (202537)
Marion Hamon (316366)
Victoria McEneaney (202543)
Sandra Roche (316367)
Jean-Pierre Gillet (316368)
John J. O’Leary (288259)
Michael Gottesman (316369)
Martin Clynes (41732)

February 2013

A) Western blot of P-glycoprotein, IGROV-1 (open bars) and IGROVCDDP (grey bars) with and without...

Viability and LM-based morphology of SH-SY5Y cells.

Cristian Vergallo (448222)
Meysam Ahmadi (665715)
Hamid Mobasheri (665716)
Luciana Dini (448228)

November 2014

A: dose-response curve of viability (MTT assay) of SH-SY5Y cells treated with different concentra...

Sphere-forming PC3 and SAS cells had higher resistance to cisplatin, but not to WA, than adherent cells.

Yukihiro Nishikawa (777979)
Daisuke Okuzaki (482418)
Kohshiro Fukushima (777980)
Satomi Mukai (777981)
Shouichi Ohno (201491)
Yuki Ozaki (589942)
Norikazu Yabuta (201494)
Hiroshi Nojima (201497)

July 2015

(A) Frequency of spheres larger than 100 μm (i) and typical images (ii) after incubation of TIG-1...

Forced expression of hsa-miR-302b increased cisplatin sensitivity in IGROV-1 cells without affecting cell proliferation.

Loris De Cecco (107073)
Martina Berardi (385975)
Michele Sommariva (385976)
Alessandra Cataldo (385977)
Silvana Canevari (136527)
Delia Mezzanzanica (385978)
Marilena V. Iorio (385979)
Elda Tagliabue (222687)
Andrea Balsari (282863)

March 2013

(A) Percent cell death of hsa-miR-302b- and scrambled-transfected cells after cisplatin treatment...

B02 increases sensitivity of 3D-growing MDA-MB-231 cells to cisplatin.

Fei Huang (9205)
Alexander V. Mazin (255463)

June 2014

A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...

Apoptosis in tumor examined by TUNEL staining.

Lihua Cheng (191638)
Chengmeng Jin (191632)
Wen Lv (112411)
Qiuping Ding (343405)
Xu Han (141301)

February 2013

(A) Microscopic evaluation of tumor apoptosis by TUNEL staining. Athymic mice bearing IGROV1-CP x...

Cell cytotoxicity assay graph showing viability at different concentrations of nanoparticles (µg/ml).

Srinivasa Sundara Rajan R. (16949220)
Jobin Thomas (4599580)
Dileep Francis (9269575)
Elcey C. Daniel (13259405)

September 2023

Cell cytotoxicity assay graph showing viability at different concentrations of nanoparticles (µg/ml)...

Microscopic examination of organs with HE staining.

Lihua Cheng (191638)
Chengmeng Jin (191632)
Wen Lv (112411)
Qiuping Ding (343405)
Xu Han (141301)

February 2013

Nude athymic mice bearing IGROV1-CP xenografts were treated with saline (control), blank nanopart...

Cytotoxicity of cisplatin in patient-derived tumor spheroids and H1299 tumor spheroids.

Zengli Zhang (4966696)
Huiqian Wang (4966687)
Qifeng Ding (4966690)
Yufei Xing (4966693)
Zhonghua Xu (116566)
Chun Lu (107478)
Dongdong Luo (4966684)
Longjiang Xu (641914)
Wei Xia (349131)
Caicun Zhou (300936)
Minhua Shi (629890)

March 2018

Cell viability was assessed using CellTiter-Glo 3D Cell Viability Assay after 72h of drug exposur...

Evaluation of cellular toxicity and viability in cisplatin-treated HK-2 cells.

Yong-Min Choi (234392)
Han-Kyul Kim (780435)
Wooyoung Shim (339309)
Muhammad Ayaz Anwar (780436)
Ji-Woong Kwon (780437)
Hyuk-Kwon Kwon (236006)
Hyung Joong Kim (780438)
Hyobin Jeong (3040872)
Hwan Myung Kim (780439)
Daehee Hwang (113308)
Hyung Sik Kim (780440)
Sangdun Choi (122038)

August 2015

HK-2 cells were treated with increasing concentrations of cisplatin (6.25–100 μM). (A) HK-2 cell ...

High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis

Hamelers, I.H.L.
Staffhorst, R.W.H.M.
Voortman, J.
de Kruijff, B.
Reedijk, J.
van Bergen en Henegouwen, P.M.P.
de Kroon, A.I.P.M.

January 2009

Purpose: Cisplatin nanocapsules, nanoprecipitates of cisplatin encapsulated in phospholipid bilayers...

Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants

Gil, Sílvia
Solano, Eduardo
Martínez-Trucharte, Francesc
Martínez-Esaín, Jordi
Pérez-Berná, Ana J.
Conesa, José Javier
Kamma-Lorger, Christina
Alsina, Mercè
Sabés Xamaní, Manuel

January 2020

The objective of this study was to regulate the cytotoxicity of cisplatin (cisPt) minimizing its adv...

Cytotoxicity assays of MCF-7 (Left) and HepG2 cells (Right) treated for 4 hours with plain nanoparticles (NP), free paclitaxel (PTX), PTX-loaded NPs (PTX-NP), PTX-loaded NPs conjugated to random DNA (PTX-R-NP), or PTX-loaded NPs conjugated to MUC1 aptamer (PTX-Apt-NP).

Chenchen Yu (345138)
Yan Hu (30839)
Jinhong Duan (331629)
Wei Yuan (64653)
Chen Wang (88408)
Haiyan Xu (148626)
Xian-Da Yang (331633)

February 2013

The cells were subsequently washed and incubated in culture media for a total of 48 hours, before...

Effect of cisplatin-loaded nanoparticles on athymic mice.

Lihua Cheng (191638)
Chengmeng Jin (191632)
Wen Lv (112411)
Qiuping Ding (343405)
Xu Han (141301)

February 2013

(A) Effect of free cisplatin (3 mg/kg) and cisplatin-loaded nanoparticles (NPs-cp, 3 mg/kg on the...

QBC939 cells are resistant to cisplatin.

Xianzhi Qu (3843163)
Jiyao Sheng (3577733)
Luyan Shen (3843166)
Jing Su (23377)
Yunjie Xu (793634)
Qi Xie (230608)
Yao Wu (598978)
Xuewen Zhang (1774840)
Liankun Sun (155927)

March 2017

QBC939 and HepG2 cells were treated with cisplatin for 12 or 24 h, and then cell viability, apopt...

P-gp in IGROV-1 and IGROVCDDP cells.

Britta Stordal (202537)
Marion Hamon (316366)
Victoria McEneaney (202543)
Sandra Roche (316367)
Jean-Pierre Gillet (316368)
John J. O’Leary (288259)
Michael Gottesman (316369)
Martin Clynes (41732)

February 2013

A) Western blot of P-glycoprotein, IGROV-1 (open bars) and IGROVCDDP (grey bars) with and without...

Viability and LM-based morphology of SH-SY5Y cells.

Cristian Vergallo (448222)
Meysam Ahmadi (665715)
Hamid Mobasheri (665716)
Luciana Dini (448228)

November 2014

A: dose-response curve of viability (MTT assay) of SH-SY5Y cells treated with different concentra...

Sphere-forming PC3 and SAS cells had higher resistance to cisplatin, but not to WA, than adherent cells.

Yukihiro Nishikawa (777979)
Daisuke Okuzaki (482418)
Kohshiro Fukushima (777980)
Satomi Mukai (777981)
Shouichi Ohno (201491)
Yuki Ozaki (589942)
Norikazu Yabuta (201494)
Hiroshi Nojima (201497)

July 2015

(A) Frequency of spheres larger than 100 μm (i) and typical images (ii) after incubation of TIG-1...

Forced expression of hsa-miR-302b increased cisplatin sensitivity in IGROV-1 cells without affecting cell proliferation.

Loris De Cecco (107073)
Martina Berardi (385975)
Michele Sommariva (385976)
Alessandra Cataldo (385977)
Silvana Canevari (136527)
Delia Mezzanzanica (385978)
Marilena V. Iorio (385979)
Elda Tagliabue (222687)
Andrea Balsari (282863)

March 2013

(A) Percent cell death of hsa-miR-302b- and scrambled-transfected cells after cisplatin treatment...

B02 increases sensitivity of 3D-growing MDA-MB-231 cells to cisplatin.

Fei Huang (9205)
Alexander V. Mazin (255463)

June 2014

A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...

Apoptosis in tumor examined by TUNEL staining.

Lihua Cheng (191638)
Chengmeng Jin (191632)
Wen Lv (112411)
Qiuping Ding (343405)
Xu Han (141301)

February 2013

(A) Microscopic evaluation of tumor apoptosis by TUNEL staining. Athymic mice bearing IGROV1-CP x...

Cell cytotoxicity assay graph showing viability at different concentrations of nanoparticles (µg/ml).

Srinivasa Sundara Rajan R. (16949220)
Jobin Thomas (4599580)
Dileep Francis (9269575)
Elcey C. Daniel (13259405)

September 2023

Cell cytotoxicity assay graph showing viability at different concentrations of nanoparticles (µg/ml)...

Microscopic examination of organs with HE staining.

Lihua Cheng (191638)
Chengmeng Jin (191632)
Wen Lv (112411)
Qiuping Ding (343405)
Xu Han (141301)

February 2013

Nude athymic mice bearing IGROV1-CP xenografts were treated with saline (control), blank nanopart...

Cytotoxicity of cisplatin in patient-derived tumor spheroids and H1299 tumor spheroids.

Zengli Zhang (4966696)
Huiqian Wang (4966687)
Qifeng Ding (4966690)
Yufei Xing (4966693)
Zhonghua Xu (116566)
Chun Lu (107478)
Dongdong Luo (4966684)
Longjiang Xu (641914)
Wei Xia (349131)
Caicun Zhou (300936)
Minhua Shi (629890)

March 2018

Cell viability was assessed using CellTiter-Glo 3D Cell Viability Assay after 72h of drug exposur...

Evaluation of cellular toxicity and viability in cisplatin-treated HK-2 cells.

Yong-Min Choi (234392)
Han-Kyul Kim (780435)
Wooyoung Shim (339309)
Muhammad Ayaz Anwar (780436)
Ji-Woong Kwon (780437)
Hyuk-Kwon Kwon (236006)
Hyung Joong Kim (780438)
Hyobin Jeong (3040872)
Hwan Myung Kim (780439)
Daehee Hwang (113308)
Hyung Sik Kim (780440)
Sangdun Choi (122038)

August 2015

HK-2 cells were treated with increasing concentrations of cisplatin (6.25–100 μM). (A) HK-2 cell ...

High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis

Hamelers, I.H.L.
Staffhorst, R.W.H.M.
Voortman, J.
de Kruijff, B.
Reedijk, J.
van Bergen en Henegouwen, P.M.P.
de Kroon, A.I.P.M.

January 2009

Purpose: Cisplatin nanocapsules, nanoprecipitates of cisplatin encapsulated in phospholipid bilayers...

Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants

Gil, Sílvia
Solano, Eduardo
Martínez-Trucharte, Francesc
Martínez-Esaín, Jordi
Pérez-Berná, Ana J.
Conesa, José Javier
Kamma-Lorger, Christina
Alsina, Mercè
Sabés Xamaní, Manuel

January 2020

The objective of this study was to regulate the cytotoxicity of cisplatin (cisPt) minimizing its adv...

Cytotoxicity assays of MCF-7 (Left) and HepG2 cells (Right) treated for 4 hours with plain nanoparticles (NP), free paclitaxel (PTX), PTX-loaded NPs (PTX-NP), PTX-loaded NPs conjugated to random DNA (PTX-R-NP), or PTX-loaded NPs conjugated to MUC1 aptamer (PTX-Apt-NP).

Chenchen Yu (345138)
Yan Hu (30839)
Jinhong Duan (331629)
Wei Yuan (64653)
Chen Wang (88408)
Haiyan Xu (148626)
Xian-Da Yang (331633)

February 2013

The cells were subsequently washed and incubated in culture media for a total of 48 hours, before...

Relative cell viability of IGROV1-CP cells with different treatments.

Abstract

Extracted data

Relative cell viability of IGROV1-CP cells with different treatments.

Abstract

Extracted data

Related items

Related items